ILD-SARDs Registry and Biorepository

Launched by MCGILL UNIVERSITY HEALTH CENTRE/RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE · Aug 10, 2021

Keywords

ClinConnect Summary

The ILD-SARDs Registry and Biorepository study is focused on understanding how certain autoimmune diseases affect the lungs. These diseases, which include conditions like rheumatoid arthritis and lupus, can lead to a type of lung disease known as interstitial lung disease (ILD). The goal of this research is to gather detailed information about patients with these conditions to identify unique features that may help explain how the lungs are affected. By studying this, researchers hope to discover new ways to treat lung problems in patients with autoimmune diseases.

To be eligible for this study, participants need to be at least 18 years old and have been diagnosed with ILD through a chest CT scan. They should also have a confirmed autoimmune disease or show some signs of autoimmunity. If you decide to participate, you’ll be asked to provide your consent and you will undergo some assessments and tests to help researchers gather the necessary information. There are no specific exclusions mentioned, so if you meet the criteria, you could contribute to important findings that may improve treatment options for others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Must be aged 18 years or older
• • 2. Diagnosis of ILD as confirmed by a chest CT
• • 3. Either a defined SARD, an undifferentiated connective tissue disease or features of autoimmunity without meeting clinical criteria for SARD
• • 4. Patient must be willing to give their informed consent and must be able to understand and follow the required study procedures.
• Exclusion Criteria:
• • N/A